Stempel JM - Search Results

1

Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insights.

Muradashvili T, Liu Y, VanOudenhove J, Gu SX, Krause DS, Montanari F, Carlino MJ, Mancuso R, Stempel JM, Halene S, Zeidan AM, Podoltsev NA, Neparidze N. Muradashvili T, et al. Among authors: stempel jm. Leuk Lymphoma. 2024 Sep 3:1-8. doi: 10.1080/10428194.2024.2393260. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39225418

2

Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea.

Wang R, Shallis RM, Stempel JM, Huntington SF, Zeidan AM, Gore SD, Ma X, Podoltsev NA. Wang R, et al. Among authors: stempel jm. Blood Adv. 2023 Mar 14;7(5):734-743. doi: 10.1182/bloodadvances.2022008259. Blood Adv. 2023. PMID: 35917456 Free PMC article.

3

Concealed by the convenient: acquired von Willebrand syndrome in myeloproliferative neoplasm requires a thorough evaluation.

Stempel JM, Podoltsev NA, Zeidan AM, Lee AI, Shallis RM. Stempel JM, et al. Ann Hematol. 2022 Nov;101(11):2559-2561. doi: 10.1007/s00277-022-04943-3. Epub 2022 Aug 19. Ann Hematol. 2022. PMID: 35984499 No abstract available.

4

Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence.

Shallis RM, Wang R, Zeidan AM, Huntington SF, Neparidze N, Stempel JM, Mendez LM, Di M, Ma X, Podoltsev NA. Shallis RM, et al. Among authors: stempel jm. Blood Adv. 2023 Jul 11;7(13):3213-3224. doi: 10.1182/bloodadvances.2022009074. Blood Adv. 2023. PMID: 36939371 Free PMC article.

5

Supportive Care for Patients With Myelodysplastic Syndromes.

Stempel JM, Podoltsev NA, Dosani T. Stempel JM, et al. Cancer J. 2023 May-Jun 01;29(3):168-178. doi: 10.1097/PPO.0000000000000661. Cancer J. 2023. PMID: 37195773 Review.

6

Evolution of Therapeutic Benefit Measurement Criteria in Myelodysplastic Syndromes/Neoplasms.

Stempel JM, Xie Z, Bewersdorf JP, Stahl M, Zeidan AM. Stempel JM, et al. Cancer J. 2023 May-Jun 01;29(3):203-211. doi: 10.1097/PPO.0000000000000666. Cancer J. 2023. PMID: 37195777 Review.

7

Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia.

Podoltsev NA, Wang R, Shallis RM, Stempel JM, Di M, Neparidze N, Zeidan AM, Huntington SF, Giri S, Hull SC, Gore SD, Ma X. Podoltsev NA, et al. Among authors: stempel jm. Cancer Med. 2023 Sep;12(18):18889-18900. doi: 10.1002/cam4.6528. Epub 2023 Sep 13. Cancer Med. 2023. PMID: 37702132 Free PMC article.

8

Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3-mutant acute myeloid leukemia.

Bewersdorf JP, Patel KK, Shallis RM, Podoltsev NA, Kewan T, Stempel J, Mendez L, Stahl M, Stein EM, Huntington SF, Goshua G, Zeidan AM. Bewersdorf JP, et al. Leuk Lymphoma. 2024 Aug;65(8):1136-1144. doi: 10.1080/10428194.2024.2344052. Epub 2024 Apr 22. Leuk Lymphoma. 2024. PMID: 38648559

9

Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions.

Bidikian A, Bewersdorf JP, Shallis RM, Getz TM, Stempel JM, Kewan T, Stahl M, Zeidan AM. Bidikian A, et al. Among authors: stempel jm. Expert Rev Anticancer Ther. 2024 Nov;24(11):1131-1146. doi: 10.1080/14737140.2024.2414071. Epub 2024 Oct 17. Expert Rev Anticancer Ther. 2024. PMID: 39367718 Review.

10

Beyond HMAs: Novel Targets and Therapeutic Approaches.

Getz TM, Bewersdorf JP, Kewan T, Stempel JM, Bidikian A, Shallis RM, Stahl M, Zeidan AM. Getz TM, et al. Among authors: stempel jm. Semin Hematol. 2024 Aug 30:S0037-1963(24)00087-8. doi: 10.1053/j.seminhematol.2024.08.001. Online ahead of print. Semin Hematol. 2024. PMID: 39389839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters